Pemigatinib
Modify Date: 2024-01-11 00:15:16
Pemigatinib structure
|
Common Name | Pemigatinib | ||
|---|---|---|---|---|
| CAS Number | 1513857-77-6 | Molecular Weight | 487.499 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C24H27F2N5O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PemigatinibPemigatinib is a selective FGFR inhibitor in development for the treatment of patients with cholangiocarcinoma. |
| Name | Pemigatinib |
|---|---|
| Synonym | More Synonyms |
| Description | Pemigatinib is a selective FGFR inhibitor in development for the treatment of patients with cholangiocarcinoma. |
|---|---|
| Related Catalog | |
| Target |
Target: FGFR[1] |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Molecular Formula | C24H27F2N5O4 |
| Molecular Weight | 487.499 |
| Exact Mass | 487.203125 |
| LogP | 0.66 |
| Index of Refraction | 1.620 |
| Storage condition | 2-8℃ |
| Pemigatinib |
| 3-(2,6-Difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(4-morpholinylmethyl)-1,3,4,7-tetrahydro-2H-pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one |
| 2H-Pyrrolo[3',2':5,6]pyrido[4,3-d]pyrimidin-2-one, 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-1,3,4,7-tetrahydro-8-(4-morpholinylmethyl)- |